n-Myc (MYCN) Rabbit Polyclonal Antibody
CAT#: TA351452
Rabbit Polyclonal Anti-MYCN Antibody
Size: 25 ul
Need it in bulk or conjugated?
Get a free quote
CNY 1999.00
CNY 3280.00
| Cited in 1 publication. |
CNY 3080.00
CNY 300.00
CNY 1430.00
Specifications
| Product Data | |
| Applications | IHC, WB |
| Recommend Dilution | WB: 200-1000 WB positive control: 293T cell lysate IHC: 50-100 Positive control: Human breast cancer Predicted cell location: Nucleus |
| Reactivity | Human, Mouse, Rat |
| Host | Rabbit |
| Clonality | Polyclonal |
| Immunogen | Synthetic peptide of human MYCN |
| Isotype | IgG |
| Formulation | pH7.4 PBS, 0.05% NaN3, 40% Glyceroln |
| Concentration | lot specific |
| Purification | Antigen affinity purification |
| Conjugation | Unconjugated |
| Storage Condition | Store at -20°C as received. |
| Gene Name | v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
| Database Link | |
| Background | This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. |
| Synonyms | bHLHe37; MODED; N-myc; NMYC; ODED |
| Reference Data | |
| Protein Families | Druggable Genome, Transcription Factors |
Citations (1)
| The use of this Antibodies has been cited in the following citations: |
|---|
|
PD-L1 is a therapeutic target of the Bromodomain inhibitor JQ1 and, combined with HLA class I, a promising prognostic biomarker in neuroblastoma
,Melaiu, O;Mina, M;Chierici, M;Boldrini, R;Jurman, G;Romania, P;D'Alicandro, V;Benedetti, MC;Castellano, A;Liu, T;Furlanello, C;Locatelli, F;Fruci, D;,
Clin. Cancer Res
,PubMed ID 28270499
[MYCN]
|
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| 抗体相关资料 |
